medica conf, page-17

1-2-3-4-5-6-7-8-9-10-11-12-13-14-15-16-17-18-19-20-21-22-23-24-25-26-27-28-29-30-31-32-33-34-35-36-37-38-39-40-41-42-43-44-45-46-47-48-49-50-51-52-53-54-55-56-57-58-59-60+


This is why it is very important not to sign an exclusive deal. These can be the death of potential for short term gain (and yes the ST gain can be very very attractive when compared to where the market values a company).

Mix&Go is known to a few hundred scientist/medicos at most and is tavelling through the commercial lens now in many of them - as this occurs the true value is being exposed.

As for the investible value - well you can see that via the top 200 and the read stats on HC - perhaps 200-300 investors and a few hundred more keeping an eye on it for a trade.

No one really knows about this technology yet and the same for ADO as an investment. Many here are in and will suceed or fail on the companies ability to sell and convince. Are GC and MB the right people to lead a charge on sell and convince.

I think so and am committed.

Of course if you offered me an up front of say . . . $1 . . . well . . . .